Infectious Diseases Market Report

Global and Region Infectious Diseases Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 29, 2022
  • PAGES：217
  • REPORT CODE：GMM885483
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Infectious Diseases market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Infectious Diseasesmarket, defines the market attractiveness level of Infectious Diseases market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Infectious Diseases industry, describes the types of Infectious Diseases market, the applications of major players and the market size, and deeply analyzes the current situation of the global Infectious Diseases market and the development prospects and opportunities of Infectious Diseases industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Infectious Diseases market in Chapter 13.

    By Player:

    • AbbVie

    • F Hoffmann-La Roche

    • Johnson & Johnson

    • Astellas Pharma

    • GlaxoSmithKline

    • Vertex

    • Eli Lilly

    • Pfizer

    • Sanofi

    • Chimerix Pharmaceuticals

    • Bristol-Myers Squibb

    • Bayer

    • Mitsubishi Tanabe Pharma

    • Merck

    • AstraZeneca

    • Novartis

    • Gilead Sciences

    • Cubist

    • Isis Pharmaceuticals

    By Type:

    • Influenza

    • HPV

    • Hepatitis

    • HIV

    • Tuberculosis

    • Others

    By End-User:

    • Hospitals/Clinical Laboratories

    • Reference Laboratories

    • Physician Offices

    • Academic/Research Institutes

    • Other

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Infectious Diseases Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Infectious Diseases Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Infectious Diseases Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Infectious Diseases Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Infectious Diseases Market Analysis and Outlook to 2022

    • 7.1 Global Infectious Diseases Consumption (2017-2022)

    • 7.2 United States Infectious Diseases Consumption (2017-2022)

    • 7.3 Europe Infectious Diseases Consumption (2017-2022)

    • 7.4 China Infectious Diseases Consumption (2017-2022)

    • 7.5 Japan Infectious Diseases Consumption (2017-2022)

    • 7.6 India Infectious Diseases Consumption (2017-2022)

    • 7.7 South Korea Infectious Diseases Consumption (2017-2022)

    8 Region and Country-wise Infectious Diseases Market Analysis and Outlook to 2028

    • 8.1 Global Infectious Diseases Consumption Forecast (2022-2028)

    • 8.2 United States Infectious Diseases Consumption Forecast (2022-2028)

    • 8.3 Europe Infectious Diseases Consumption Forecast (2022-2028)

    • 8.4 China Infectious Diseases Consumption Forecast (2022-2028)

    • 8.5 Japan Infectious Diseases Consumption Forecast (2022-2028)

    • 8.6 India Infectious Diseases Consumption Forecast (2022-2028)

    • 8.7 South Korea Infectious Diseases Consumption Forecast (2022-2028)

    9 Global Infectious Diseases Market Outlook by Types and Applications to 2022

    • 9.1 Global Infectious Diseases Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Influenza Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global HPV Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Hepatitis Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global HIV Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Tuberculosis Consumption and Growth Rate (2017-2022)

      • 9.1.6 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global Infectious Diseases Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospitals/Clinical Laboratories Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Reference Laboratories Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Physician Offices Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Academic/Research Institutes Consumption and Growth Rate (2017-2022)

      • 9.2.5 Global Other Consumption and Growth Rate (2017-2022)

    10 Global Infectious Diseases Market Outlook by Types and Applications to 2028

    • 10.1 Global Infectious Diseases Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Influenza Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global HPV Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Hepatitis Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global HIV Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.5 Global Tuberculosis Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.6 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Infectious Diseases Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospitals/Clinical Laboratories Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Reference Laboratories Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Physician Offices Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Academic/Research Institutes Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.5 Global Other Consumption Forecast and Growth Rate (2022-2028)

    11 Global Infectious Diseases Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Infectious Diseases Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Infectious Diseases Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Infectious Diseases Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Infectious Diseases Market Competitive Analysis

    • 14.1 AbbVie

      • 14.1.1 AbbVie Company Details

      • 14.1.2 AbbVie Infectious Diseases Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 AbbVie Infectious Diseases Product and Service

    • 14.2 F Hoffmann-La Roche

      • 14.2.1 F Hoffmann-La Roche Company Details

      • 14.2.2 F Hoffmann-La Roche Infectious Diseases Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 F Hoffmann-La Roche Infectious Diseases Product and Service

    • 14.3 Johnson & Johnson

      • 14.3.1 Johnson & Johnson Company Details

      • 14.3.2 Johnson & Johnson Infectious Diseases Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Johnson & Johnson Infectious Diseases Product and Service

    • 14.4 Astellas Pharma

      • 14.4.1 Astellas Pharma Company Details

      • 14.4.2 Astellas Pharma Infectious Diseases Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Astellas Pharma Infectious Diseases Product and Service

    • 14.5 GlaxoSmithKline

      • 14.5.1 GlaxoSmithKline Company Details

      • 14.5.2 GlaxoSmithKline Infectious Diseases Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 GlaxoSmithKline Infectious Diseases Product and Service

    • 14.6 Vertex

      • 14.6.1 Vertex Company Details

      • 14.6.2 Vertex Infectious Diseases Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Vertex Infectious Diseases Product and Service

    • 14.7 Eli Lilly

      • 14.7.1 Eli Lilly Company Details

      • 14.7.2 Eli Lilly Infectious Diseases Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Eli Lilly Infectious Diseases Product and Service

    • 14.8 Pfizer

      • 14.8.1 Pfizer Company Details

      • 14.8.2 Pfizer Infectious Diseases Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Pfizer Infectious Diseases Product and Service

    • 14.9 Sanofi

      • 14.9.1 Sanofi Company Details

      • 14.9.2 Sanofi Infectious Diseases Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Sanofi Infectious Diseases Product and Service

    • 14.10 Chimerix Pharmaceuticals

      • 14.10.1 Chimerix Pharmaceuticals Company Details

      • 14.10.2 Chimerix Pharmaceuticals Infectious Diseases Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Chimerix Pharmaceuticals Infectious Diseases Product and Service

    • 14.11 Bristol-Myers Squibb

      • 14.11.1 Bristol-Myers Squibb Company Details

      • 14.11.2 Bristol-Myers Squibb Infectious Diseases Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Bristol-Myers Squibb Infectious Diseases Product and Service

    • 14.12 Bayer

      • 14.12.1 Bayer Company Details

      • 14.12.2 Bayer Infectious Diseases Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 Bayer Infectious Diseases Product and Service

    • 14.13 Mitsubishi Tanabe Pharma

      • 14.13.1 Mitsubishi Tanabe Pharma Company Details

      • 14.13.2 Mitsubishi Tanabe Pharma Infectious Diseases Sales, Price, Value and Gross Profit (2017-2022)

      • 14.13.3 Mitsubishi Tanabe Pharma Infectious Diseases Product and Service

    • 14.14 Merck

      • 14.14.1 Merck Company Details

      • 14.14.2 Merck Infectious Diseases Sales, Price, Value and Gross Profit (2017-2022)

      • 14.14.3 Merck Infectious Diseases Product and Service

    • 14.15 AstraZeneca

      • 14.15.1 AstraZeneca Company Details

      • 14.15.2 AstraZeneca Infectious Diseases Sales, Price, Value and Gross Profit (2017-2022)

      • 14.15.3 AstraZeneca Infectious Diseases Product and Service

    • 14.16 Novartis

      • 14.16.1 Novartis Company Details

      • 14.16.2 Novartis Infectious Diseases Sales, Price, Value and Gross Profit (2017-2022)

      • 14.16.3 Novartis Infectious Diseases Product and Service

    • 14.17 Gilead Sciences

      • 14.17.1 Gilead Sciences Company Details

      • 14.17.2 Gilead Sciences Infectious Diseases Sales, Price, Value and Gross Profit (2017-2022)

      • 14.17.3 Gilead Sciences Infectious Diseases Product and Service

    • 14.18 Cubist

      • 14.18.1 Cubist Company Details

      • 14.18.2 Cubist Infectious Diseases Sales, Price, Value and Gross Profit (2017-2022)

      • 14.18.3 Cubist Infectious Diseases Product and Service

    • 14.19 Isis Pharmaceuticals

      • 14.19.1 Isis Pharmaceuticals Company Details

      • 14.19.2 Isis Pharmaceuticals Infectious Diseases Sales, Price, Value and Gross Profit (2017-2022)

      • 14.19.3 Isis Pharmaceuticals Infectious Diseases Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Infectious Diseases

    • Figure Infectious Diseases Picture

    • Table Global Infectious Diseases Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Infectious Diseases Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Infectious Diseases Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Infectious Diseases Consumption by Country (2017-2022)

    • Figure United States Infectious Diseases Consumption and Growth Rate (2017-2022)

    • Table Europe Infectious Diseases Consumption and Growth Rate (2017-2022)

    • Figure China Infectious Diseases Consumption and Growth Rate (2017-2022)

    • Figure Japan Infectious Diseases Consumption and Growth Rate (2017-2022)

    • Figure India Infectious Diseases Consumption and Growth Rate (2017-2022)

    • Figure South Korea Infectious Diseases Consumption and Growth Rate (2017-2022)

    • Figure Global Infectious Diseases Consumption Forecast by Country (2022-2028)

    • Figure United States Infectious Diseases Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Infectious Diseases Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Infectious Diseases Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Infectious Diseases Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Infectious Diseases Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Infectious Diseases Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Influenza Consumption and Growth Rate (2017-2022)

    • Figure Global HPV Consumption and Growth Rate (2017-2022)

    • Figure Global Hepatitis Consumption and Growth Rate (2017-2022)

    • Figure Global HIV Consumption and Growth Rate (2017-2022)

    • Figure Global Tuberculosis Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Hospitals/Clinical Laboratories Consumption and Growth Rate (2017-2022)

    • Figure Global Reference Laboratories Consumption and Growth Rate (2017-2022)

    • Figure Global Physician Offices Consumption and Growth Rate (2017-2022)

    • Figure Global Academic/Research Institutes Consumption and Growth Rate (2017-2022)

    • Figure Global Other Consumption and Growth Rate (2017-2022)

    • Figure Global Influenza Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global HPV Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hepatitis Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global HIV Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Tuberculosis Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospitals/Clinical Laboratories Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Reference Laboratories Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Physician Offices Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Academic/Research Institutes Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Infectious Diseases Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Infectious Diseases Export by Region (Top 5 Countries) (2017-2028)

    • Table AbbVie (Foundation Year, Company Profile and etc.)

    • Table AbbVie Infectious Diseases Sales, Price, Value and Gross Profit (2017-2022)

    • Table AbbVie Infectious Diseases Product and Service

    • Table F Hoffmann-La Roche (Foundation Year, Company Profile and etc.)

    • Table F Hoffmann-La Roche Infectious Diseases Sales, Price, Value and Gross Profit (2017-2022)

    • Table F Hoffmann-La Roche Infectious Diseases Product and Service

    • Table Johnson & Johnson (Foundation Year, Company Profile and etc.)

    • Table Johnson & Johnson Infectious Diseases Sales, Price, Value and Gross Profit (2017-2022)

    • Table Johnson & Johnson Infectious Diseases Product and Service

    • Table Astellas Pharma (Foundation Year, Company Profile and etc.)

    • Table Astellas Pharma Infectious Diseases Sales, Price, Value and Gross Profit (2017-2022)

    • Table Astellas Pharma Infectious Diseases Product and Service

    • Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)

    • Table GlaxoSmithKline Infectious Diseases Sales, Price, Value and Gross Profit (2017-2022)

    • Table GlaxoSmithKline Infectious Diseases Product and Service

    • Table Vertex (Foundation Year, Company Profile and etc.)

    • Table Vertex Infectious Diseases Sales, Price, Value and Gross Profit (2017-2022)

    • Table Vertex Infectious Diseases Product and Service

    • Table Eli Lilly (Foundation Year, Company Profile and etc.)

    • Table Eli Lilly Infectious Diseases Sales, Price, Value and Gross Profit (2017-2022)

    • Table Eli Lilly Infectious Diseases Product and Service

    • Table Pfizer (Foundation Year, Company Profile and etc.)

    • Table Pfizer Infectious Diseases Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Infectious Diseases Product and Service

    • Table Sanofi (Foundation Year, Company Profile and etc.)

    • Table Sanofi Infectious Diseases Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi Infectious Diseases Product and Service

    • Table Chimerix Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Chimerix Pharmaceuticals Infectious Diseases Sales, Price, Value and Gross Profit (2017-2022)

    • Table Chimerix Pharmaceuticals Infectious Diseases Product and Service

    • Table Bristol-Myers Squibb (Foundation Year, Company Profile and etc.)

    • Table Bristol-Myers Squibb Infectious Diseases Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bristol-Myers Squibb Infectious Diseases Product and Service

    • Table Bayer (Foundation Year, Company Profile and etc.)

    • Table Bayer Infectious Diseases Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bayer Infectious Diseases Product and Service

    • Table Mitsubishi Tanabe Pharma (Foundation Year, Company Profile and etc.)

    • Table Mitsubishi Tanabe Pharma Infectious Diseases Sales, Price, Value and Gross Profit (2017-2022)

    • Table Mitsubishi Tanabe Pharma Infectious Diseases Product and Service

    • Table Merck (Foundation Year, Company Profile and etc.)

    • Table Merck Infectious Diseases Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck Infectious Diseases Product and Service

    • Table AstraZeneca (Foundation Year, Company Profile and etc.)

    • Table AstraZeneca Infectious Diseases Sales, Price, Value and Gross Profit (2017-2022)

    • Table AstraZeneca Infectious Diseases Product and Service

    • Table Novartis (Foundation Year, Company Profile and etc.)

    • Table Novartis Infectious Diseases Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis Infectious Diseases Product and Service

    • Table Gilead Sciences (Foundation Year, Company Profile and etc.)

    • Table Gilead Sciences Infectious Diseases Sales, Price, Value and Gross Profit (2017-2022)

    • Table Gilead Sciences Infectious Diseases Product and Service

    • Table Cubist (Foundation Year, Company Profile and etc.)

    • Table Cubist Infectious Diseases Sales, Price, Value and Gross Profit (2017-2022)

    • Table Cubist Infectious Diseases Product and Service

    • Table Isis Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Isis Pharmaceuticals Infectious Diseases Sales, Price, Value and Gross Profit (2017-2022)

    • Table Isis Pharmaceuticals Infectious Diseases Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US